Skip to content

Public FDA record

Z-1009-2023: Alinity m System. The Alinity m System is designed to automate the steps for nucleic acid testing, whi

Recall record Z-1009-2023 for Abbott Molecular, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1009-2023
Company in FDA record
Abbott Molecular, Inc.
FDA classification date
Jan 20, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The firm identified the following three potential issues which may have impacted ADUs installed on distributed Alinity m Systems. 1. Systems which had their ADUs serviced may have an incorrect board value (calibration data file) referenced causing a misconfiguration of the calibration. 2. Inability of Maintenance and Diagnostics 2300 (Amp Detect Optical Calibrations) to recognize error handling and thermal hold errors during the calibration process, potentially leading to a misconfiguration of the calibration. 3. Under specific conditions during the ADU manufacturing process, an incorrect calibration may potentially have been configured.

Source facts

Action
On December 09, 2022, Abbott Molecular issued a Field Correction Recall/Urgent Field Safety Notice to all customers who have the Alinity m System by FedEx priority overnight express. The letter explained the problems and provided the following information: "An assessment of your Alinity m System associated with the above listed potential issues will be completed remotely if your system is currently connected to AbbottLink or alternatively via onsite inspection by an Abbott representative. If necessary, an Abbott representative will schedule time to corrected the affected ADU9s) on your Alinity m System(s). In the interim, please continue to follow your laboratory protocols for any suspected incorrect results. Following the assessment and any necessary service, an additional communication will follow. If it is determined that your instrument was impacted, please assess the impact to your laboratory in reviewing previously generated test results. This recall is to be carried out at the user/customer level. If this product has been further distributed by your facility, please notify any additional impacted customers. Please review this information with laboratory personnel and retain this communication for future reference. If you have any questions regarding the communication, please contact your local Abbott representative, or call Abbott Technical Support at 1-800-553-7042 Option 2."
Initiated
2022-12-09
Root cause
Under Investigation by firm
Distribution
x
Recall number
Z-1009-2023
Recall status
Open, Classified
CDRH record ID
197382
FDA classified
2023-01-20
Recall event number
91286

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗